Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Transformative System for Medical Information, Osaka University Graduate School of Medicine, Osaka, Japan.
J Atheroscler Thromb. 2024 Feb 1;31(2):158-170. doi: 10.5551/jat.64274. Epub 2023 Aug 19.
Both recurrent myocardial infarction (ReMI) and bleeding events after acute myocardial infarction (AMI) were reportedly associated with increased mortality. To date, the prognostic impact of these events on subsequent outcomes in East Asians is still unclear. In this study, we aimed to investigate the impact of bleeding or thrombotic events during acute phase on subsequent mortality and time-dependent change of the impact in patients with AMI undergoing percutaneous coronary intervention (PCI).
We conducted a prospective, multicenter, observational study of patients with AMI (n=12,093). The patients who did not undergo emergent PCI were excluded. In addition, the patients registered before 2003 were excluded because the data of bleeding severity was not obtained. Eligible patients were divided into two groups based on the occurrence of major bleeding within 7 days of PCI, and the same approach was performed for ReMI within 7 days of PCI. The endpoint of this study was all-cause death. We assessed the impact of major bleeding and ReMI, which occurred within 7 days of index PCI, on the subsequent clinical outcomes up to 5 years.
A total of 6,769 patients were found to be eligible. All-cause death occurred in 898 (13.3%) patients during a median follow-up period of 1,726 [511-1,840] days. After adjustment for multiple confounders, major bleeding in 7 days from index PCI was independently associated with higher 30-day and 30-day to 1-year mortality (odds ratio [OR]: 2.06 [1.45-2.92] p<0.001, OR: 2.03 [1.28-3.15] p=0.002), whereas ReMI was not (OR: 1.93 [0.92-3.80] p=0.07, OR: 0.81 [0.24-2.03] p=0.68). Major bleeding and ReMI did not affect mortality between 1 and 5 years (hazard ratio [HR]: 1.32 [0.77-2.26] p=0.31, HR: 0.48 [0.12-1.94] p=0.30).
Major bleeding in 7 days from admission was independently associated with higher 30-day and 1-year mortality but not during 1-5 years. ReMI did not affect mortality in all phases. We should be more concerned about bleeding event during acute phase after PCI.
据报道,复发性心肌梗死(ReMI)和急性心肌梗死(AMI)后的出血事件与死亡率增加有关。迄今为止,这些事件对东亚人后续结果的预后影响仍不清楚。在这项研究中,我们旨在研究 AMI 患者行经皮冠状动脉介入治疗(PCI)期间急性期出血或血栓形成事件对随后死亡率的影响,以及这些影响随时间的变化。
我们进行了一项前瞻性、多中心、观察性研究,纳入了 12093 名 AMI 患者。排除了未行紧急 PCI 的患者。此外,排除了 2003 年前登记的患者,因为未获得出血严重程度的数据。根据 PCI 后 7 天内是否发生主要出血,将符合条件的患者分为两组,对于 PCI 后 7 天内发生 ReMI 的患者,同样的方法进行。本研究的终点为全因死亡。我们评估了 PCI 后 7 天内发生的主要出血和 ReMI 对随后 5 年内的临床结局的影响。
共发现 6769 名符合条件的患者。在中位随访 1726[511-1840]天期间,共有 898 名(13.3%)患者发生全因死亡。在校正多个混杂因素后,PCI 后 7 天内发生的主要出血与较高的 30 天和 30 天至 1 年死亡率独立相关(优势比[OR]:2.06[1.45-2.92]p<0.001,OR:2.03[1.28-3.15]p=0.002),而 ReMI 则不然(OR:1.93[0.92-3.80]p=0.07,OR:0.81[0.24-2.03]p=0.68)。主要出血和 ReMI 并未影响 1 至 5 年期间的死亡率(风险比[HR]:1.32[0.77-2.26]p=0.31,HR:0.48[0.12-1.94]p=0.30)。
入院后 7 天内的主要出血与较高的 30 天和 1 年死亡率独立相关,但与 1-5 年期间无关。ReMI 对所有阶段的死亡率均无影响。我们应更加关注 PCI 后急性期的出血事件。